Start for free
Start for free
Forepont Capital Partners logo

Forepont Capital Partners

North America, New York, United States, New York

Description

Forepont Capital Partners provides permanent capital to invest in the asset manager and strengthen this partnership.

Investor Profile

Forepont Capital Partners has made 10 investments, with 2 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (40%)
  • Series B (30%)
  • Series C (10%)
  • Series Unknown (10%)
  • Seed (10%)

Country Focus

  • United States (50%)
  • Australia (30%)
  • France (20%)

Industry Focus

  • Medical
  • Medical Device
  • Biotechnology
  • Manufacturing
  • Computer
  • Information Technology
  • Marketing
  • Neuroscience
  • Product Research
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Forepont Capital Partners frequently co-invest with?

Shanda Group
Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 2
University of Melbourne
University of Melbourne
Oceania, New South Wales, Australia, Parkville
Co-Investments: 2
ID8 Investments
ID8 Investments
North America, New York, United States, New York
Co-Investments: 2
General Advance
General Advance
North America, New York, United States, New York
Co-Investments: 2
METIS innovative
METIS innovative
North America, Florida, United States, Miami Beach
Co-Investments: 2
Subversive Capital
Subversive Capital
North America, New York, United States, New York
Co-Investments: 2
re.Mind Capital
re.Mind Capital
Europe, NA - Malta, Malta, Sliema
Co-Investments: 2
NI
Neurotechnology Investors
North America, California, United States, Palo Alto
Co-Investments: 2
Alumni Ventures
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
Khosla Ventures
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Forepont Capital Partners often collaborate with?

TR
Thomas Reardon
North America, Rhode Island, United States, Providence
Shared Deals: 1
Michael Gregg
Michael Gregg
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
AB
Arani Bose
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Forepont Capital Partners?

AlterDiag

Clermont-ferrand, Auvergne, France

AlterDiag is a Developer of rapid diagnostic tests using single-domain antibodies.

BiotechnologyMedical
SeedJan 29, 2025
Amount Raised: $2,084,940
GPN Vaccines

Adelaide, South Australia, Australia

GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

Biotechnology
Series BJun 6, 2024
Amount Raised: $11,984,580
basecamp vascular

Reims, Champagne-Ardenne, France

basecamp vascular is a medtech company that offers a Robotic solution for endovascular navigation.

MedicalMedical DeviceRobotics
Series ADec 13, 2023
Amount Raised: $6,529,589
GPN Vaccines

Adelaide, South Australia, Australia

GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

Biotechnology
Series AJan 31, 2023
Amount Raised: $6,345,898
Precision Neuroscience

New York, New York, United States

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

MedicalMedical DeviceNeuroscienceProduct Research
Series BJan 25, 2023
Amount Raised: $41,000,000
Synchron

Brooklyn, New York, United States

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

ComputerInformation TechnologyManufacturingMarketingMedicalMedical Device
Series CDec 15, 2022
Amount Raised: $75,000,000
Mobius Biomedical

Lowell, Massachusetts, United States

Mobius Biomedical is developing the next generation biologics manufacturing technology with unprecedented efficiencies at commercial scale.

BiopharmaBiotechnologyHealth CareIndustrial EngineeringIndustrial ManufacturingManufacturingMedicalPharmaceutical
Series UnknownMar 28, 2022
Synchron

Brooklyn, New York, United States

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

ComputerInformation TechnologyManufacturingMarketingMedicalMedical Device
Series BJun 3, 2021
Amount Raised: $40,000,000
Precision Neuroscience

New York, New York, United States

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

MedicalMedical DeviceNeuroscienceProduct Research
Series AMay 25, 2021
Amount Raised: $12,000,000
GPN Vaccines

Adelaide, South Australia, Australia

GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

Biotechnology
Series AJun 30, 2020
Amount Raised: $4,830,701
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator